INKT Company Profile and Key Details
MiNK Therapeutics, Inc.
INKT Stock Price Chart
Stock Price Today
MiNK Therapeutics, Inc. (INKT) stock surged +6.32%, trading at $1.01 on NASDAQ, up from the previous close of $0.95. The stock opened at $0.90, fluctuating between $0.87 and $1.07 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases, which is in Phase 1 clinical trials. The company was formerly known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. was incorporated in 2017 and is based in New York, New York. MiNK Therapeutics, Inc. operates as a subsidiary of Agenus Inc.
Company Information
| Employees | 31 |
| Beta | 0.05 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | -1% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
MiNK Therapeutics, Inc. (NASDAQ: INKT) stock price is $1.01 in the last trading session. During the trading session, INKT stock reached the peak price of $1.07 while $0.87 was the lowest point it dropped to. The percentage change in INKT stock occurred in the recent session was 6.32% while the dollar amount for the price change in INKT stock was $0.06.
The NASDAQ listed INKT is part of Biotechnology industry that operates in the broader Healthcare sector. MiNK Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Marcus Antonius van Dijk Ph.D.
Chief Scientific Officer
Mr. Patrick N. Jordan M.B.A.
Vice President of Bus. Operations
Joy Zhou Ph.D.
Vice President & Head of CMC
Ms. Kimberly Ha
Head of Investor Relations
Ms. Heather Boussios
Gen. Counsel & Chief Compliance Officer
INKT's closing price is 118.14% higher than its 52-week low of $0.46 where as its distance from 52-week high of $1.90 is -46.84%.
Number of INKT employees currently stands at 31.
Official Website of INKT is: https://minktherapeutics.com
INKT could be contacted at phone 212 994 8250 and can also be accessed through its website. INKT operates from 149 Fifth Avenue, New York, NY 10010, United States.
INKT stock volume for the day was 413.34K shares. The average number of INKT shares traded daily for last 3 months was 102.08K.
The market value of INKT currently stands at $39.95M with its latest stock price at $1.01 and 39.55M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com